Back to Search
FURHAN YUNUS, MD
MD
Hematology & Oncology Physician
NPI: 1326048356IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
26582(TN)15052(MS)C8166(AR)MD.207786(LA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1985
Research & Publications (14)
Incidence and risk factors of bisphosphonate-associated osteonecrosis of the jaws.
PMID 18853454·Head Neck·2009
8-other
Multiple myeloma. Clinical practice guidelines in oncology.
PMID 17335683·J Natl Compr Canc Netw·2007
6-review
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.
PMID 16766588·Ann Oncol·2006
3-trial
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma.
PMID 16009588·Pulm Pharmacol Ther·2006
4-observational
Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer.
PMID 15277257·Ann Oncol·2004
3-trial
Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin's lymphoma.
PMID 14692520·Leuk Lymphoma·2003
4-observational
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer.
PMID 12401903·Oncologist·2002
3-trial
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer.
PMID 11870159·J Clin Oncol·2002
3-trial
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.
PMID 11208851·J Clin Oncol·2001
8-other
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
PMID 11205920·Clin Cancer Res·2001
3-trial
Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.
PMID 10981290·Oncology (Williston Park)·2000
6-review
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
PMID 10863062·Int J Radiat Oncol Biol Phys·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1514 JEFFERSON HWY
NEW ORLEANS, LA 70121 - Phone
- (504) 842-3910
Quick Facts
- NPI
- 1326048356
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 41
- Publications
- 14
Are you this provider?
Claim Your Profile